June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Prevalence of Dry Eye Disease in Rheumatoid Arthritis Patients
Author Affiliations & Notes
  • Jasmine Wong Yumori
    Optometry, Western University of Health Sciences, Pomona, CA
  • Dat Trinh
    Family Medicine, Western University of Health Sciences, Pomona, CA
  • Eric Lee
    Inland Rheumatology & Osteoporosis Medical Group, Upland, CA
  • Tina Escobedo
    Inland Rheumatology & Osteoporosis Medical Group, Upland, CA
    Graduate Nursing, Western University of Health Sciences, Pomona, CA
  • Gillian Hollands
    Optometry, Western University of Health Sciences, Pomona, CA
  • Robert Gordon
    Optometry, Western University of Health Sciences, Pomona, CA
  • Cheng-Tong Wang
    Sociology, University of California, Irvine, Irvine, CA
  • Thang Le
    Inland Rheumatology & Osteoporosis Medical Group, Upland, CA
  • Anthony Hou
    Inland Rheumatology & Osteoporosis Medical Group, Upland, CA
  • Michael Finley
    Clinical Affairs, Western University of Health Sciences, Pomona, CA
  • Footnotes
    Commercial Relationships Jasmine Yumori, Allergan (F), TearLab (F); Dat Trinh, None; Eric Lee, None; Tina Escobedo, None; Gillian Hollands, None; Robert Gordon, None; Cheng-Tong Wang, None; Thang Le, None; Anthony Hou, None; Michael Finley, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4437. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jasmine Wong Yumori, Dat Trinh, Eric Lee, Tina Escobedo, Gillian Hollands, Robert Gordon, Cheng-Tong Wang, Thang Le, Anthony Hou, Michael Finley; Prevalence of Dry Eye Disease in Rheumatoid Arthritis Patients. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4437.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Patients with rheumatoid arthritis (RA) often present to non-eye care practitioners with dry eye disease (DED) symptoms but without a clinical diagnosis of DED. We completed a prospective, observational 1-visit multi-center clinical study to determine the prevalence of DED on a large RA patient population recruited from non-eye care settings.

 
Methods
 

286 adult RA patients completed a rheumatologic and dry eye evaluation. All patients were asked to self-report a clinical diagnosis of DED. The mean age of patients was 58 years old; 14.3% were male and 85% were female, with unavailable gender information for 0.70%. The following rheumatologic tests were performed: Disease Activity Score in 28 joints (DAS28) and Cyclic Citruillinated Peptide IgG antibody (CCP IgG), C - Reactive Protein (CRP), and Rheumatoid Factor (RF) labs. The following dry eye tests were performed: Ocular Surface Disease Index® (OSDI), tear osmolarity (TO), tear break-up time (TBUT), corneal/conjunctival staining, and Schirmer test (ST) without anesthetic. A Modified Dry Eye WorkShop (DEWS) Severity Scale (Table 1) was created to quantify DED severity level. A DED severity level was determined for each eye by averaging the severity level for each test. The eye with the higher DED severity level was used to identify each patient’s overall DED severity level. Patients with an overall DED severity level greater than Level 1 were defined as having DED.

 
Results
 

Data from the 286 RA patients was analyzed. 44% of patients reported a clinical diagnosis of DED. Mean rheumatologic test results were: DAS28 3.04±1.40, CCP IgG 91.77±105.80, CRP 0.58±1.58, and RF 77.44±109.73. Mean dry eye test results were: OSDI 37.21±25.54, TO 316.26±16.32, TBUT 4.20±2.05, staining 4.45±4.52, and ST 11.15±8.99. The prevalence of DED (overall DED severity level greater than Level 1) in RA patients recruited from non-eye care settings is 96.15%. 34.27% of RA patients had an overall severity of at least Level 3.

 
Conclusions
 

In this population of RA patients recruited from non-eye care settings there is a strong association between RA and DED. Earlier diagnosis and treatment of DED in collaboration with non-eye care professionals and eye care professionals in RA patients is essential.<br />  

 
Table 1: Modified DEWS Severity Scale
 
Table 1: Modified DEWS Severity Scale

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×